Skip to content
Open access

ISRIB regulates UFMylation system homeostasis in fibroblasts to attenuate ER stress–associated inflammation and cellular senescence

Nov 2026 · Frontiers in Pharmacology · 0 citations · 34 references

Abstract

Intervertebral disc degeneration (IVDD) is a major contributor to chronic low back pain, but effective treatments that target the underlying disease process remain limited. In this study, we investigated the therapeutic potential of targeting the DDRGK1/UFMylation system to reduce endoplasmic reticulum (ER) stress, inflammation, and cellular senescence in fibroblasts. We demonstrated that ISRIB, a selective ER stress inhibitor, significantly suppressed thapsigargin (Tg)-induced inflammatory responses and reduced DDRGK1 expression in rat fibroblasts. Notably, overexpression of DDRGK1, a key component of the UFMylation system, alleviated ER stress and improved protein quality control, effectively reversed Tg-induced cellular senescence, restored proliferation capacity, and attenuated the expression of inflammatory markers. Importantly, in vivo experiments using a needle-puncture rat tail model of IVDD confirmed that DDRGK1 overexpression significantly ameliorated intervertebral disc degeneration. These findings indicate that ISRIB attenuates ER stress–associated inflammatory and senescent phenotypes in fibroblasts, and that DDRGK1 overexpression alleviates disc degeneration in a rat tail puncture model, suggesting the UFMylation system as a potential therapeutic target for IVDD. warranting further validation in disc-derived cells.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.